Joint research and development of high-function products centered on the Life Science Research Institute

「従来の商品機能別の構成から肌悩み別のスキンケアラインへの再編を進め、その第一弾として、2026年９月に乾燥ケアライン「Moist Plus（モイスト プラス）」をリニューアル発売いたしました。」

「In food products, the Company thoroughly confirmed the scientific basis for functionality and managed safety and quality under the Foods with Function Claims system. It relaunched the Foods with Function Claims “Bifidus Mix W (Double)” and “Meimei Gen.” It also launched the supplement-type “Michi Puru Stick” and drink-type “Michi Puru Rich” in September 2025 as products designed to make HABA Inner- and Outer-Beauty® easier to incorporate into daily life, and relaunched the supplement “E×A” with added vitamin D as “E×A×D” in February 2026.」

「The Group's research and development activity expenses for the six-month interim consolidated period were ¥57.181 million. There was no material change in the status of the Group's research and development activities during the period.」

「As a result, the Company launched 3 standard products as relaunches, including “Squa Facial Soap,” “Fluffy Volume Hair Treatment” and “Squa Creamy Foaming Face Wash,” 21 limited-edition new products, including “Squa Cleansing Balm Charcoal & Clay,” “Roll-On Skin Oil,” “Powdery Shining Concealer,” “Floral Lift Squalane,” “Winter Story Collection,” “Squalane Spa Lotion Bergamot” and “Medicated Moisture Control Base,” and 1 limited-edition relaunched product, “Refreshing Body Oil.” In food products, the Company conducted tests for confirming active ingredients, nutritional analysis and shelf-life storage tests for each product. As a result, it launched Job's Tears Green Juice containing the Company's original ingredient “HABA Fermented Enzyme-Ripened Job's Tears®” in December. It also launched “Wakawaka Gen,” containing the notable anti-aging ingredient NMN, for sale exclusively in stores in January.」

「In January, the Company comprehensively relaunched all 39 standard makeup products for the first time in 8 years, comprising 7 medicated base makeup products, 5 other base makeup products, 12 color makeup products and 15 makeup accessories such as puffs and cases. In February, it relaunched 7 UV-care products, including “UV Cut 30,” “UV Cut 50” and “UV Kids Gel.” As a result, total research and development expenses for the fiscal year were ¥125.108 million, or 1.0% of sales.」

「The Group's research and development activity expenses for the nine months ended the third quarter were ¥95.790 million. There was no material change in the status of the Group's research and development activities during the period.」

「In addition, on 22 January 2024, the Company will comprehensively relaunch and newly launch the HABA additive-free skincare makeup series.」

「During the fiscal year, the Company launched the cosmetic products “Gray Hair Cover Foundation” in April, “VC30 Pure Skin Serum” in June, “Medicated Moisturizing Ceramide Milk” as a standard product in September, “Smooth Moist Heel Rich” in November and “Serum Cushion BB” in February, and relaunched 7 UV-care products, including “UV Cut 30,” “UV Cut 50” and “UV Kids Gel,” in February. In food products, it launched the Foods with Function Claims “Shinkyugen” in April, “Nentaigen” in May, 3 varieties including “Marvy Cookie Cacao” and “Marvy Cookie Almond” in September, and the Foods with Function Claims “HABA Job's Tears Tea” in October. As a result, total research and development expenses for the fiscal year were ¥176.400 million, or 1.5% of sales.」

「The Group's research and development activity expenses for the nine months ended the third quarter were ¥129.326 million. There was no material change in the status of the Group's research and development activities during the period.」

「The Group's research and development activity expenses for the three months ended the first quarter were ¥43.527 million. There was no material change in the status of the Group's research and development activities during the period.」

「During the fiscal year, the Company launched the cosmetic products “Waterproof Jelly Foundation” in May, “Squalane Shampoo Cool Citrus” and “Squalane Conditioner Cool Citrus” in July, “Squa Cleansing (Lavender)” in August, “Scalp Massage Cleanse” in October and “Moist Base EX Frosty Lavender” in January. In food products, it launched 3 varieties of the Foods for Specified Health Uses “Oligo One Yogurt Sour,” “Oligo One Pine Yogurt” and “Oligo One Strawberry Yogurt” in September, the Foods with Function Claims “Junkatsu Gen” in February and “Meikaku Gen” in March. As a result, total research and development expenses for the fiscal year were ¥152.565 million, or 1.2% of sales.」

「The Group's research and development activity expenses for the nine months ended the third quarter were ¥112.643 million. There was no material change in the status of the Group's research and development activities during the period.」

「The Group's research and development activity expenses for the six months ended the second quarter were ¥75.014 million. There was no material change in the status of the Group's research and development activities during the period.」

「The Group's research and development activity expenses for the three months ended the first quarter were ¥40.315 million. There was no material change in the status of the Group's research and development activities during the period.」

「During the fiscal year, the Company launched the cosmetic products “Lavender Squalane” in August, “Moisturizing Squalane Stick” and “Aroma Mask Spray” in December, “Refreshing Body Oil” in January and “Rose Squalane” in February. As a result, total research and development expenses for the fiscal year were ¥148.949 million, or 1.0% of sales.」

「The Group's research and development activity expenses for the nine months ended the third quarter were ¥110.264 million. There was no material change in the status of the Group's research and development activities during the period.」

「The Group's research and development activity expenses for the six months ended the second quarter were ¥73.301 million. There was no material change in the status of the Group's research and development activities during the period.」

「The Group's research and development activity expenses for the three months ended the first quarter were ¥34.490 million. There was no material change in the status of the Group's research and development activities during the period.」

「During the fiscal year, the Company launched the cosmetic products “Slim Face Gel” in October, “Moisturizing Hand Milk” in November, “Moisturizing Foaming Body Wash” in December and “Rose Sea Jewel” in March. As a result, total research and development expenses for the fiscal year were ¥150.214 million, or 0.8% of sales.」

「The Group's research and development activity expenses for the nine months ended the third quarter were ¥113.170 million. There was no material change in the status of the Group's research and development activities during the period.」

「The Group's research and development activity expenses for the six months ended the second quarter were ¥80.270 million. There was no material change in the status of the Group's research and development activities during the period.」

「The Group's research and development activity expenses for the three months ended the first quarter were ¥32.358 million. There was no material change in the status of the Group's research and development activities during the period.」

「During the fiscal year, the Company launched the cosmetic products “Squalane Spa Lotion” in September and “UV Cut 30 (sunscreen)” and “UV Cut 50 (sunscreen)” in March. As a result, total research and development expenses for the fiscal year were ¥170.552 million, or 0.9% of sales.」

「The Group's research and development activity expenses for the nine months ended the third quarter were ¥145.463 million. There was no material change in the status of the Group's research and development activities during the period.」

「This was primarily attributable to ¥180.729 million in expenditures for the acquisition of tangible fixed assets, including expansions of research and development facilities and factory equipment, and ¥98.780 million in expenditures for the acquisition of intangible fixed assets consisting of software for new systems and other purposes.」

「The Group's research and development activity expenses for the three months ended the first quarter were ¥41.565 million. There was no material change in the status of the Group's research and development activities during the period.」

「During the fiscal year, the Company launched the cosmetic products “Smooth Matte Base” in April and “Deep Moist Serum” in September. In health foods, it launched “HABA Propolis Moisture Extreme Throat Drops.” As a result, total research and development expenses for the fiscal year were ¥213.501 million, or 1.2% of sales.」

「The Group's research and development activity expenses for the nine months ended the third quarter were ¥169.760 million. There was no material change in the status of the Group's research and development activities during the period.」

「The Group's research and development activity expenses for the six months ended the second quarter were ¥127.523 million. There was no material change in the status of the Group's research and development activities during the period.」

「The Group's research and development activity expenses for the three months ended the first quarter were ¥59.205 million. There was no material change in the status of the Group's research and development activities during the period.」

「Centered on the Life Science Research Institute, the Company will develop new technologies and materials through joint research with universities and other research institutions, as well as specialized research into substances, materials and raw ingredients, and will develop high-function products by applying these technologies and materials to cosmetics, food products and other areas.」

「Centered on the Life Science Research Institute, the Company will develop new technologies and materials through joint research with universities and other research institutions, as well as specialized research into substances, materials and raw ingredients, and will develop high-function products by applying these technologies and materials to cosmetics, food products and other areas.」

「Centered on the Life Science Research Institute, the Company will develop new technologies and materials through joint research with universities and other research institutions, as well as specialized research into substances, materials and raw ingredients, and will develop high-function products by applying these technologies and materials to cosmetics, food products and other areas.」

「Centered on the Life Science Research Institute, the Company will develop new technologies and materials through joint basic research with universities and other research institutions, as well as specialized research into substances, materials and raw ingredients, and will develop high-function products by applying these technologies and materials to cosmetics, food products and other areas.」